Haemocoagulase Agkistrodon

尖吻蝮蛇血凝酶

Report date: 2026/01/27 10:16:47
NME

Base Information

Drug NameHaemocoagulase Agkistrodon
Drug Alias Name尖吻蝮蛇蛇毒凝血酶苏灵
ClassificationNatural product/Extract
Mechanisms of ActionFibrinogen stimulants
TargetsFibrinogen
Therapy Area/IndicationsPostoperative HemorrhageBlood Loss, SurgicalIntervertebral Disc Displacement
Global Approved IndicationsPostoperative HemorrhageBlood Loss, Surgical
Approved Indications in ChinaPostoperative HemorrhageBlood Loss, Surgical
Original Approved Country/TerritoryMainland China
Original Approved Date2008/09/22
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBeijing Konruns Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBeijing Konruns Pharmaceutical Co LtdSouth China Center For Innovative PharmaceuticalsGuangdong Ruisheng Pharmaceutical Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsPostoperative HemorrhageBlood Loss, SurgicalIntervertebral Disc Displacement
Inactive IndicationsN/A

Other Information

ATC CodeB02
Related LinksN/A